Goodwin Procter LLP advised Envisagenics on the deal.Envisagenics announced its collaboration with Biogen Inc. (Nasdaq: BIIB) to advance ribonucleic acid (RNA) splicing research within central nervous system…
Envisagenics’ Collaboration with Biogen Inc.

























